Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Endoscopic Submucosal Dissection Esd

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06033976Recruiting

Endoscopic Submucosal Dissection Registry

NCT05839002CompletedPrimary

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT

Showing all 2 trials

Research Network

Common Treatments

  • Endoscopic Submucosal Dissection Esd1
  • Ncrt1

Active Sponsors

  • Carol Davila University of Medicine and Pharmacy1
  • Shanghai Zhongshan Hospital1
  • Fudan University1

Top Investigators

Related Conditions

  • Neoplasm Stomach1
  • Neoplasm Squamous Cell1
  • Neoplasm Colorectal1
  • Neoplasm Duodenal1

Activity Timeline